North America Immunochemistry Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Immunochemistry Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Immunochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Immunochemistry Market Regional Analysis

6.2 North America Immunochemistry Market Revenue 2016-2027 (US$ Million)

6.3 North America Immunochemistry Market Forecast Analysis

7. North America Immunochemistry Market Analysis – by Application

7.1 Diagnostics

7.1.1 Overview
7.1.2 Diagnostics: North America Immunochemistry Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.2 Drug Testing

7.2.1 Overview
7.2.2 Drug Testing: North America Immunochemistry Market – Revenue and Forecast, 2016-2027 (US$ Million)

8. North America Immunochemistry Market Analysis – by Product

8.1 Antibodies

8.1.1 Overview
8.1.2 Antibodies: North America Immunochemistry Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.2 Equipment

8.2.1 Overview
8.2.2 Equipment: North America Immunochemistry Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.3 Reagents

8.3.1 Overview
8.3.2 Reagents: North America Immunochemistry Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.4 Kits

8.4.1 Overview
8.4.2 Kits: North America Immunochemistry Market – Revenue and Forecast, 2016-2027 (US$ Million)

9. North America Immunochemistry Market Analysis – by End User

9.1 Hospitals and Diagnostic Laboratories

9.1.1 Overview
9.1.2 Hospitals and Diagnostic Laboratories: North America Immunochemistry Market – Revenue and Forecast, 2016-2027 (US$ Million)

9.2 Research Institutes

9.2.1 Overview
9.2.2 Research Institutes: North America Immunochemistry Market – Revenue and Forecast, 2016-2027 (US$ Million)

10. North America Immunochemistry Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Immunochemistry Market Breakdown, by Key Country, 2019 and 2027 (%)
10.2.1.1 North America Immunochemistry Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 US: North America Immunochemistry Market Breakdown, by Application
10.2.1.1.2 US: North America Immunochemistry Market Breakdown, by Product
10.2.1.1.3 US: North America Immunochemistry Market Breakdown, by End User

10.2.1.2 Canada: North America Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Canada: North America Immunochemistry Market Breakdown, by Application
10.2.1.2.2 Canada: North America Immunochemistry Market Breakdown, by Product
10.2.1.2.3 Canada: North America Immunochemistry Market Breakdown, by End User

10.2.1.3 Mexico : North America Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 Mexico : North America Immunochemistry Market Breakdown, by Application
10.2.1.3.2 Mexico : North America Immunochemistry Market Breakdown, by Product
10.2.1.3.3 Mexico : North America Immunochemistry Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 PerkinElmer, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Abcam Plc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Agilent Technologies,

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Bio SB

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Bio-Rad Laboratories, Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Cell Signalling Technology, Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 F. Hoffmann-La Roche Ltd.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Danaher

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Merck KGaA

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Thermo Fisher Scientific, Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Immunochemistry Market

Analysis and Forecasts By Application (Diagnostics, Drug Testing); Product (Antibodies, Equipment, Reagents, Kits); End User (Hospitals and Diagnostic Laboratories, Research Institutes, Others), and Country